Insufficient scRNA-seq data for expression of CLEC2A at single-cell level.
Insufficient scRNA-seq data for expression of CLEC2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 71% | 568.08 | 1277 / 1809 | 3% | 0.07 | 13 / 472 |
uterus | 0% | 0 | 0 / 170 | 15% | 2.88 | 70 / 459 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.83 | 6 / 45 |
esophagus | 0% | 0 | 0 / 1445 | 5% | 0.80 | 10 / 183 |
bladder | 0% | 0 | 0 / 21 | 5% | 1.05 | 27 / 504 |
lung | 0% | 0 | 0 / 578 | 5% | 0.93 | 53 / 1155 |
ovary | 0% | 0 | 0 / 180 | 2% | 0.06 | 9 / 430 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.27 | 3 / 178 |
breast | 0% | 0 | 0 / 459 | 1% | 0.05 | 15 / 1118 |
intestine | 0% | 0 | 0 / 966 | 1% | 0.12 | 5 / 527 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.03 | 2 / 286 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.01 | 3 / 605 |
brain | 0% | 0.34 | 9 / 2642 | 0% | 0.00 | 1 / 705 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.01 | 1 / 502 |
adipose | 0% | 0.25 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.48 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0005886 | Cellular component | plasma membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CLEC2A |
Protein name | C-type lectin domain family 2 member A (Keratinocyte-associated C-type lectin) (KACL) (Proliferation-induced lymphocyte-associated receptor) (PILAR) |
Synonyms | UNQ5792/PRO19597 KACL |
Description | FUNCTION: Plays a role in modulating the extent of T-cell expansion. Enhances the expansion of TCR-stimulated T-cells by increasing their survival through enhanced expression of anti-apoptotic proteins. May modulate the capacity of T-cells to home to lymph nodes through SELL. Facilitates dedicated immune recognition of keratinocytes via interaction with its receptor KLRF2 by stimulating natural killer cell mediated cytotoxicity. . |
Accessions | Q6UVW9 ENST00000455827.2 [Q6UVW9-1] ENST00000339766.8 [Q6UVW9-2] |